Scarica l'app Stockscreener
1.87
0.54%
0.01
Dopo l'orario di chiusura:
1.87
Precedente Chiudi:
$1.86
Aprire:
$1.91
Volume 24 ore:
1.18M
Relative Volume:
0.10
Capitalizzazione di mercato:
$64.41M
Reddito:
-
Utile/perdita netta:
$-20.34M
Rapporto P/E:
-2.6829
EPS:
-0.697
Flusso di cassa netto:
$-15.59M
1 W Prestazione:
-15.00%
1M Prestazione:
-36.18%
6M Prestazione:
+47.24%
1 anno Prestazione:
-12.62%
Intervallo 1D:
$1.86
$2.03
Intervallo di 1 settimana:
$1.86
$2.24
Portata 52W:
$0.54
$4.00
Heartbeam Inc Stock (BEAT) Company Profile
Nome
Heartbeam Inc
Settore
Industria
Telefono
408-899-4443
Indirizzo
2118 WALSH AVE., SUITE 210, SANTA CLARA
Confronta BEAT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BEAT
Heartbeam Inc
|
1.87 | 64.07M | 0 | -20.34M | -15.59M | -0.697 |
|
VEEV
Veeva Systems Inc
|
225.28 | 36.12B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
68.36 | 11.62B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
40.80 | 7.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
86.42 | 7.23B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
39.60 | 7.08B | 11.99B | 24.18M | 234.31M | 0.2956 |
Heartbeam Inc Stock (BEAT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-11 | Aggiornamento | The Benchmark Company | Speculative Buy → Buy |
| 2025-12-08 | Iniziato | H.C. Wainwright | Buy |
| 2025-10-31 | Iniziato | Roth Capital | Buy |
| 2020-09-11 | Iniziato | Needham | Buy |
| 2020-09-02 | Iniziato | Robert W. Baird | Neutral |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-08-02 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2019-04-26 | Reiterato | Dougherty & Company | Buy |
| 2018-07-26 | Reiterato | Lake Street | Buy |
| 2018-04-26 | Reiterato | The Benchmark Company | Buy |
| 2018-02-23 | Reiterato | Dougherty & Company | Buy |
| 2017-11-08 | Reiterato | Dougherty & Company | Buy |
| 2017-10-26 | Iniziato | Raymond James | Outperform |
| 2017-10-24 | Iniziato | SunTrust | Buy |
| 2017-08-09 | Reiterato | Dougherty & Company | Buy |
| 2017-07-19 | Reiterato | The Benchmark Company | Buy |
| 2017-04-11 | Reiterato | Dougherty & Company | Buy |
| 2016-12-02 | Iniziato | Dougherty & Company | Buy |
| 2016-09-13 | Iniziato | Sidoti | Buy |
| 2016-08-03 | Reiterato | The Benchmark Company | Buy |
| 2015-07-28 | Reiterato | Dougherty & Company | Buy |
| 2013-10-24 | Iniziato | The Benchmark Company | Buy |
| 2013-08-21 | Iniziato | Dougherty & Company | Buy |
Mostra tutto
Heartbeam Inc Borsa (BEAT) Ultime notizie
Heartbeam, Inc. Appoints Bryan Humbarger as Chief Commercial Officer, Effective January 22, 2026 - marketscreener.com
HeartBeam (NASDAQ: BEAT) Appoints Bryan Humbarger as Chief Commercial Officer - TipRanks
HeartBeam Appoints Bryan Humbarger as Chief Commercial Officer - BioSpace
HeartBeam appoints Bryan Humbarger as chief commercial officer - Investing.com
Sectors Review: Can HeartBeam Inc maintain its current growth rate2025 Technical Patterns & Free Weekly Chart Analysis and Trade Guides - baoquankhu1.vn
Trend Review: Is GSR III Acquisition Corp. showing insider buyingWeekly Stock Summary & Comprehensive Market Scan Insights - baoquankhu1.vn
Activity Recap: How does Roper Technologies Inc perform in inflationary periodsMarket Trend Review & Breakout Confirmation Alerts - baoquankhu1.vn
Recap Report: Can HeartBeam Inc Equity Warrant stock sustain revenue growthPortfolio Gains Report & Technical Pattern Recognition Alerts - Bộ Nội Vụ
Aug Gainers: Should value investors consider HeartBeam Inc2025 Bull vs Bear & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
FDA Clearance for HeartBeam (NASDAQ: BEAT) Highlighted in Medical Device Approvals Roundup - TradingView — Track All Markets
What Wall Street predicts for HeartBeam Inc. Equity Warrant stock price2025 Historical Comparison & Weekly Watchlist of Top Performers - ulpravda.ru
FDA Clearance for HeartBeam (BEAT) Highlighted in Medical Device Approvals Roundup - NewMediaWire
About Us - FinancialContent
How HeartBeam Inc. stock performs in interest rate cyclesQuarterly Market Review & Fast Entry High Yield Stock Tips - Улправда
Will HeartBeam Inc. stock benefit from automationQuarterly Market Summary & Technical Entry and Exit Tips - ulpravda.ru
Is HeartBeam Inc. Equity Warrant stock safe for conservative investorsMarket Growth Review & Accurate Entry/Exit Alerts - ulpravda.ru
What sentiment indicators say about HeartBeam Inc. stock2025 Technical Overview & Short-Term Trading Alerts - Улправда
Can HeartBeam Inc. Equity Warrant stock outperform in 2025 bull marketQuarterly Trade Report & Stepwise Trade Signal Guides - Улправда
Is HeartBeam Inc. Equity Warrant stock a safe haven assetRecession Risk & Short-Term High Return Strategies - Улправда
HeartBeam shares skyrocket after FDA signs off on 12-lead ECG synthesis software - MSN
AeroVironment Stock Surges: Military Gains Explored - StocksToTrade
Will HeartBeam Inc. Equity Warrant stock benefit from upcoming earnings reports2025 Retail Activity & Daily Market Momentum Tracking - ulpravda.ru
Can HeartBeam Inc. stock hit analyst price targetsGap Fill Strategies & Low Risk Capital Growth - ulpravda.ru
HeartBeam (BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - NewMediaWire
HeartBeam (NASDAQ: BEAT) to attend JP Morgan 2026 annual healthcare conference - MSN
HeartBeam (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - TradingView — Track All Markets
HeartBeam to Attend JP Morgan 2026 Annual Healthcare Conference - 01net
NetworkNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) to Attend JP Morgan 2026 Annual Healthcare Conference - FinancialContent
Trend Recap: Is HeartBeam Inc stock recession proofMarket Trend Review & Weekly Watchlist for Consistent Profits - moha.gov.vn
How HeartBeam Inc. Equity Warrant stock reacts to global recession fearsGlobal Trade Effects & Small Budget Trading Ideas - bollywoodhelpline.com
Pharma News: What sentiment indicators say about HeartBeam Inc stockRisk Management & High Conviction Investment Ideas - moha.gov.vn
HeartBeam seeks FDA nod for ECG synthesis software - MSN
HeartBeam Stock Slumps After FDA Refuses Clearance For ECG Software - MSN
Major HeartBeam Investor Makes Bold Move With Eye-Catching Stock Sale - TipRanks
Heartbeam Insider Sold Shares Worth $895,000, According to a Recent SEC Filing - marketscreener.com
Earnings Beat: How institutional buying supports Alector Inc stock2025 Market WrapUp & Weekly Breakout Opportunity Watchlist - moha.gov.vn
Will HeartBeam Inc. stock deliver shareholder value2025 Macro Impact & Free Real-Time Market Sentiment Alerts - ulpravda.ru
How HeartBeam Inc. stock performs in stagflation2025 Volatility Report & Low Risk Investment Opportunities - Улправда
Trend Report: Will HeartBeam Inc. stock deliver shareholder valueMarket Activity Summary & Free High Accuracy Swing Entry Alerts - Улправда
Can HeartBeam Inc. stock double in next 5 yearsWeekly Profit Recap & Step-by-Step Trade Execution Guides - Улправда
Patterns Watch: Can HeartBeam Inc. stock hit analyst price targetsPortfolio Update Summary & Weekly Sector Rotation Insights - ulpravda.ru
HeartBeam Director George de Urioste Sells All Common Stock Holdings - TradingView — Track All Markets
How risky is HeartBeam Inc. Equity Warrant stock nowJuly 2025 Decliners & Expert Verified Movement Alerts - Улправда
Is HeartBeam Inc. Equity Warrant stock a bargain at current levels2025 Market WrapUp & Free Expert Verified Stock Movement Alerts - Улправда
How institutional buying supports HeartBeam Inc. Equity Warrant stockPrice Action & High Accuracy Investment Signals - Улправда
Why HeartBeam Inc. Equity Warrant stock is a must watch in 2025Gap Up & Daily Entry Point Trade Alerts - DonanımHaber
Is HeartBeam Inc. stock dividend yield sustainable2025 Biggest Moves & Long Hold Capital Preservation Tips - Улправда
Will HeartBeam Inc. Equity Warrant stock deliver consistent dividendsWeekly Profit Summary & Stepwise Trade Signal Guides - DonanımHaber
Heartbeam Inc Azioni (BEAT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.15%
2.25%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):